EIGER BIOPHARMACEUTICALS
Eiger BioPharmaceuticals is a privately held biotechnology company that develops a novel antiviral therapy for Hepatitis Delta, a life-threatening, Orphan Disease with high unmet medical need and no approved therapy. The company is led by a management team experienced in the development and commercialization of rare disease therapeutics. Its strategy is predicated upon time and cost-efficient drug development, with the goal of delivering safe and effective therapies to patients.
EIGER BIOPHARMACEUTICALS
Social Links:
Industry:
Biotechnology Health Care Medical
Founded:
2008-01-01
Address:
San Carlos, California, United States
Country:
United States
Website Url:
http://www.eigerbio.com
Total Employee:
11+
Status:
Active
Contact:
(650)272-6138
Email Addresses:
[email protected]
Total Funding:
156.26 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics Font Awesome
Similar Organizations
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2015-11-18 | Celladon | Celladon acquired by Eiger BioPharmaceuticals | N/A |
Investors List
Innovatus Capital Partners
Innovatus Capital Partners investment in Post-IPO Equity - Eiger BioPharmaceuticals
Innovatus Capital Partners
Innovatus Capital Partners investment in Post-IPO Debt - Eiger BioPharmaceuticals
Oxford Finance LLC
Oxford Finance LLC investment in Post-IPO Debt - Eiger BioPharmaceuticals
InterWest Partners
InterWest Partners investment in Debt Financing - Eiger BioPharmaceuticals
InterWest Partners
InterWest Partners investment in Series A - Eiger BioPharmaceuticals
Vivo Capital
Vivo Capital investment in Series A - Eiger BioPharmaceuticals
InterWest Partners
InterWest Partners investment in Series A - Eiger BioPharmaceuticals
Vivo Capital
Vivo Capital investment in Series A - Eiger BioPharmaceuticals
RA Capital Management
RA Capital Management investment in Seed Round - Eiger BioPharmaceuticals
Key Employee Changes
Official Site Inspections
http://www.eigerbio.com Semrush global rank: 2.28 M Semrush visits lastest month: 8.31 K
- Host name: 104.26.6.198
- IP address: 104.26.6.198
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Eiger BioPharmaceuticals"
Eiger BioPharmaceuticals - Crunchbase Company …
Contact Email [email protected] Phone Number (650)272-6138 Eiger BioPharmaceuticals is a privately held biotechnology company that develops a novel antiviral therapy for Hepatitis Delta, a life-threatening, Orphan Disease …See details»
Eiger BioPharmaceuticals, Inc. - AnnualReports.com
Eiger is a biopharmaceutical company focused on the discovery and development of new antiviral agents against novel targets in the treatment of hepatitis.See details»
Eiger BioPharmaceuticals Company Overview, Contact Details ...
Jun 7, 2022 Eiger BioPharmaceuticals. Biotechnology Research United States 11-50 Employees. Eiger is a commercial-stage biopharmaceutical company focused on the …See details»
Eiger BioPharmaceuticals - Craft
Sep 24, 2024 Eiger BioPharmaceuticals has 5 employees at their 1 location and $15.77 m in annual revenue in FY 2023. See insights on Eiger BioPharmaceuticals including office …See details»
Eiger Appoints Senior Human Resources and ... - Markets Insider
Jul 18, 2022 Prior to her leadership position with the Boston Medical Center Health System, Ms. Kelly-Croswell led Human Resources for Vertex Pharmaceuticals, playing a pivotal role in the …See details»
Eiger Appoints Senior Human Resources and Organizational …
Jul 18, 2022 Prior to her leadership position with the Boston Medical Center Health System, Ms. Kelly-Croswell led Human Resources for Vertex Pharmaceuticals, playing a pivotal role in the …See details»
Working at Eiger BioPharmaceuticals - Zippia
Www.eigerbio.com. Organization Type. Public. CEO. David A. Cory. Social Media. Eiger BioPharmaceuticals is a privately held biotechnology company developing a novel antiviral …See details»
Organization: Eiger BioPharmaceuticals LEI …
Eiger BioPharmaceuticals. Information about the issuer. News and credit ratings. (LEI 549300GO4VMIHDKJNU46). Tables with accounting and financial reporting.See details»
Eiger BioPharmaceuticals Strengthens Leadership Team with New …
Apr 18, 2022 Prior to Adamas, Sarah served as Chief Executive Officer for Research Autism, a non-profit organization focused on autism research and education in the UK. She previously …See details»
Eiger BioPharmaceuticals, Inc. - Cruelty Free Investing
Eiger BioPharmaceuticals, Inc. is a clinical-stage company, which engages in the research, development, and commercialization of biopharmaceutical products. It focuses on product …See details»
Eiger BioPharmaceuticals to Focus on Metabolic Diseases with
Jun 29, 2023 The live and replayed webcast of the call will be available through the company's website at www.eigerbio.com. To participate in the live call by phone, dial (866) 524-3160 …See details»
Eiger BioPharmaceuticals Appoints Industry Veteran Eldon Mayer …
Jan 7, 2020 Eldon Mayer was most recently Executive Vice President and Chief Commercial Officer of Rigel Pharmaceuticals where he built and led the commercial organization of over 60 …See details»
Eiger BioPharmaceuticals Strengthens Leadership Team with New …
Apr 18, 2022 About Eiger Eiger is a commercial-stage biopharmaceutical company focused on the development of innovative therapies to treat and cure Hepatitis Delta Virus (HDV) and …See details»
Eiger BioPharmaceuticals to Focus on Metabolic Diseases with …
Jun 29, 2023 The live and replayed webcast of the call will be available through the company's website at www.eigerbio.com. To participate in the live call by phone, dial (866) 524-3160 …See details»
Eiger BioPharmaceuticals Strengthens Leadership Team with New …
--Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company focused on the development of innovative therapies to treat and cure Hepatitis Delta Virus and other serious …See details»
Eiger BioPharmaceuticals Strengthens Management Team with …
Apr 13, 2023 William G. Kachioff appointed as Chief Financial Officer; James A. Vollins appointed as General Counsel, Chief Compliance Officer and Corporate Secretary; PALO …See details»
Eiger BioPharmaceuticals Receives Rare Impact Award for …
Jun 29, 2021 PRF is the only non-profit organization solely dedicated to finding treatments and the cure for Progeria and its aging-related conditions, including heart disease. ... Email: …See details»
Eiger BioPharmaceuticals, Inc. (EIGR) CEO David Cory on Q2 2021 …
Aug 8, 2021 Eiger BioPharmaceuticals, Inc. (EIGR) Q2 2021 Earnings Conference Call August 5, 2021 4:30 PM ETCompany ParticipantsSri Ryali - Chief Financial OfficerDavid...See details»
Eiger BioPharmaceuticals Announces First Patients Dosed with ...
Jul 6, 2021 Eiger BioPharmaceuticals Announces First Patients Dosed with Peginterferon Lambda in Phase 3 TOGETHER Study of Newly Diagnosed COVID-19 OutpatientsSee details»
Eiger BioPharmaceuticals Receives Rare Impact Award for …
Jun 29, 2021 PRF is the only non-profit organization solely dedicated to finding treatments and the cure for Progeria and its aging-related conditions, including heart disease. ...See details»